-
ChromaDex is a
dietary supplement and food
ingredient company based in Los Angeles,
California founded in 1999 that is
publicly traded on the NASDAQ....
-
director of
business development at 20th
Century Fox. He
became the CEO of
ChromaDex in 2018. From 1983 to 1990,
Fried held
various executive positions. He...
-
nicotinamidase Pnc1.
ChromaDex licensed patents in July 2012, and
began to
develop a
process to
bring NR to
market as TruNiagen.
ChromaDex has been in a patent...
-
stopped paying ChromaDex,
ChromaDex sued
Elysium and the
information became public. In
September 2018,
Dartmouth College and
ChromaDex sued
Elysium for...
- Therapeutics,
Vaccines Strategic Investments: ARNO Therapuetics, BioCardia,
ChromaDex Corporation,
Cocrystal Pharma, MABVAX, Neovasc, Pharmsynthez, RXi Pharmaceuticals...
- Amex).
According to the most
recent SEC Filings, Frost’s
ownership in
Chromadex is
about 3.15%,
split between individual ownership and his foundation...
- to its
acquisition by
ChromaDex, and
serves as
member of the
scientific advisory board and
chief scientific advisor to
ChromaDex. 2020, Mary
Swartz Rose...
- 2012). "What Does Gold Bond
Medicated Powder and
Ovaltine Have to Do With
ChromaDex Corp. (CDXC)?
Sanofi SA (SNY) &
Nestle (NSRGY)".
Smallcap Network. Archived...
-
considered too
toxic for use.
Hooker reaction [1]
Lapochol at R&D Chemicals. "
ChromaDex Incorporated General Product Information for LAPACHOL(RG)".
Archived from...
- China. Mogroside,
related compounds also
found in S. grosvenorii.
Siamenoside I on www.
chromadex.com
Media related to
Siamenoside I at
Wikimedia Commons...
